SCHEMBL17532425

SCHEMBL17532425

O=C1C2C3CCC(O3)C2C(=O)N1CCCCCCN1C(=O)C2C3CCC(O3)C2C1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 3/20 0.48
PPM1B O75688 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GMNN O75496 1/20 0.43
LMNA P02545 1/20 0.43
PPP1CC P36873 1/20 0.43
TFPI2 P48307 1/20 0.43
PPP5C P53041 1/20 0.43
PPP1CA P62136 1/20 0.43
PMP22 Q01453 1/20 0.43
TP53 P04637 1/20 0.43
CYP2D6 P10635 1/20 0.43
NFKB1 P19838 1/20 0.43
THPO P40225 1/20 0.43
CNR2 P34972 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17532421 0.94 ALDH1A1 (0.46) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL13311489 0.94 ALDH1A1 (0.46) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL3495647 0.91 CNR2 (0.53) RAB9AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL3496388 0.91 CNR2 (0.53) RAB9AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL17532429 0.90 PPM1B (0.48) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL13311411 0.87 PPM1B (0.52) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL3494259 0.87 SMN1; SMN2 (0.51) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL13311412 0.83 PPM1B (0.55) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL3497073 0.82 PPM1B (0.42) RAB9AMEN1KMT2AALDH1A1PPM1B
SCHEMBL13311367 0.82 L3MBTL1 (0.42) RAB9AMEN1KMT2AALDH1A1PPM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160370522-A1 CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-12-22 US disclosed
US-20160370522-A1 CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-12-22 US disclosed
US-20160039994-A1 OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed
US-20160039994-A1 OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039994-A1 OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE VCL, L1CAM, F12 RAB9A 2151/4885MEN1 1479/4885KMT2A 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.